The Myelodysplastic Syndromes Channel on VJHemOnc is an independent medical education platform, supported with funding from Geron (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
SOHO 2024 | Ongoing studies in HR-MDS: VERONA and SELECT MDS-1
David Sallman, MD, Moffitt Cancer Center, Tampa, FL, gives an overview of ongoing investigational studies in myelodysplastic syndromes (MDS), drawing focus on trials in higher-risk MDS. Some of the studies highlighted include the VERONA trial (NCT04401748) and the SELECT MDS-1 trial (NCT04797780). This interview took place at the Twelfth Annual Meeting of the Society of Hematologic Oncology (SOHO 2024) congress in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
